ABSTRACT
INTRODuCTION
According to the Third Global Myocardial Infarction Task Force, acute myocardial infarction (AMI) has been defined as necrosis of the cardiac cells triggered by extended ischemia that leads to specific clinical, electrocardiographic, and laboratory changes. 1 The clinical correspondent of an AMI typically includes non-localized chest pain usually lasting for more than 20 minutes, with specific radiation sites and associated shortness of breath, fatigue to various risk prediction tools. [2] [3] [4] Serum biomarkers illustrating myocardial injury and necrosis that have been used for diagnosis include the traditional troponin levels, serum myoglobin, creatinekinase myocardial-brain isoenzyme, and the more novel heart-type fatty acid-binding protein and copeptin that can detect acute coronary syndromes (ACS) within the early hours from onset. 5 Simultaneously, laboratory markers have also been used for risk prognosis assessment in complex multi-marker risk prediction tools, which can be applied before and after the acute coronary event, thus depicting the characteristics of the so-called 'vulnerable patient', who is at risk for either an initial ACS or for further complications following the acute event.
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Cardiovascular vulnerability refers not only to the presence of unstable coronary atherosclerotic plaques, but also to the vulnerable blood and vulnerable myocardium, all enmeshed into a complex, novel concept: the vulnerable patient. 10 The thrombogenic vulnerable blood is characterized as presenting increased levels of inflammatory mediators (C-reactive protein, interleukins, vascular cell adhesion molecules, soluble ligand CD40, leukocytosis), enhanced coagulability and platelet aggregation, as well as associated hypoalbuminemia, thrombocytosis, and hyperlipidemia, and is specifically defined as prone to arterial and venous thrombosis. 8, 10, 11 Hypoalbuminemia has been shown to associate with all-cause mortality rates, as well as with cardiovascular deaths. 12, 13 The serum level of albumin is determined by various factors such as synthesis and catabolic rates, extracellular distribution, and exogenous elimination. Its synthesis is decreased by the interrelation between the poor nutritional status and enhanced systemic inflammation, the latter also triggering a greater catabolic rate. 13, 14 Therefore, the decreased nutritional status of the cardiovascular patient may poorly influence serum albumin levels and stimulate systemic inflammation, which in turn will affect blood homeostasis towards a high propensity for blood vulnerability and subsequent high cardiovascular risk. 8, 10 Serum albumin has been introduced in several scores that assess the overall nutritional status of subjects admitted in the hospital.
The Controlling Nutritional Status (CONUT) score has been introduced in 2005 as a tool for malnutrition screening in hospitalized subjects, and its calculation is based on three serum parameters: albumin, total cholesterol, and total lymphocyte count. 15 The score represents an efficient tool for early identification and continuous control of evaluating the protein reserve, immune status, and caloric depletion in subjects admitted in the hospital for various cardiac and non-cardiac disorders, and has been associated with a high risk of complications and worse outcomes. [16] [17] [18] The prognostic nutritional index (PNI) score uses 2 serum parameters: albumin and lymphocyte levels. The score reflects the immune and nutritional status and can indicate systemic inflammation, and is associated with higher mortality in surgical, medical, cardiovascular, and oncological patients.
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Although the negative influence of a poor nutritional status has been evaluated in previous studies on the prognosis and outcome of stable and decompensated chronic heart failure patients, 16, 21, 23 
MATERIALS AND METHODS
We conducted a prospective, observational study on 56
consecutive patients with acute ST and non-ST elevation myocardial infarction admitted in the Intensive Car- are at mild risk of malnutrition, those with a CONUT score of 5-8 are at moderate risk, and those with a CONUT score of 9-12 are at severe risk.
The study population was divided into 2 groups according to the calculated CONUT score, as follows: group 1 -CONUT score <3 points, specifically patients with normal to mildly impaired nutritional status, and group 2 -CONUT score ≥3 points, subjects with moderate to severe malnutrition.
The primary end-point of the study consisted in the rate of in-hospital complications including left ventricular free wall rupture, hemodynamic instability requiring inotropic medication, high-degree atrioventricular block, the need for temporary cardiostimulation, supraventricular and ventricular arrhythmias, and in-hospital cardiac arrest. The secondary end-points included the duration of hospitalization and the length of stay in the intensive care unit.
RESuLTS
The study included 56 patients with AMI (44.64%, n = 25
with STEMI and 55.35%, n = 31 with NSTEMI). The mean age of the study population was 61.96 ± 13.42 years, and 58.92% (n = 33) were males.
According to the CONUT score, the study population was divided into 2 groups: group 1 included 43 patients (76.78%) with normal to mildly depressed nutritional status and a CONUT score of <3 points, while group 2 included 13 patients (23.21%) with moderate to severe malnutrition, with calculated CONUT scores of ≥3 points.
The baseline characteristics of the total study population, as well as of the two CONUT groups are listed in Table 1 . There were no statistically significant differences between the two CONUT groups regarding age, gender, body mass index, provenance, nor in relation to the cardiovascular risk factors of medical history of cardiovascular diseases (Table 1 ). The body mass index was 28.8 ± 6.5 kg/m 2 for the overall study populations, and no significant difference was recorded between the two patient groups The laboratory tests of the overall study population, as well as those of the two CONUT groups are listed in Table   2 . No significant differences were found between the two groups regarding the renal function parameters, myocardial necrosis enzymes, or triglyceride levels. However, as expected, the serum albumin was significantly lower Table 2 ).
The primary end-point of the study consisting in the rate of complications that had occurred during hospitalization is illustrated in Figure 1 . In total, 17.8% (n = 10) of subjects were hemodynamically unstable requiring inotropic therapy, 1.78% (n = 1) presented high-degree atrioventricular block which required the use of a temporary pacemaker, 12.5% (n = 7) and 7.14% (n = 4) presented ventricular and supraventricular arrhythmias respectively, 
DISCuSSIONS
The present study primarily aimed to identify the relationship between an impaired nutritional status and inhospital complications, as well as with the clinical profile and the hospitalization period in patients with AMI who were admitted in a tertiary intensive cardiac care unit.
The nutritional status of the patients has been recently studied as having significant impact on prognosis, in a sense that malnutrition can negatively impact patient outcomes in various chronic disorders, from oncological to cardiovascular disease, and from chronic heart failure to stable coronary artery disease, myocardial infarction, or lower limb ischemia.
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Evaluation of the nutritional status could become a new prognostic marker for such patients, while dietary supplements and malnutrition corrective therapies may beneficially influence the prognosis of patients with chronic heart failure. 25, 26 The CONUT score (Controlling Nutritional Status), based on the levels of serum albumin, total cholesterol, and lymphocyte count, has been developed as a simple, cost-efficient screening tool for impaired nutrition in hospitalized subjects. The CONUT index classifies the nutritional status into normal, lightly decreased, moderate, and severely impaired. 15 Serum albumin, also included in the CONUT score, is a multifunctional human protein influenced by various factors, including the nutritional status and enhanced systemic inflammation. Furthermore, low serum albumin has also been linked to all-cause mortality and cardiovascular mortality and was associated with malnutrition, a pro-inflammatory and a pro-thrombotic status, all accounting for the definition of vulnerable blood, as a part of a larger concept: the vulnerable cardiovascular patient. 8, 13 The results of the current investigation also found low levels of albumin in undernourished patients with AMI. Concomitantly, subjects with malnutrition and AMI in our study presented lower serum cholesterol levels compared to controls, which could further influence lipid-lowering therapies, as hypocholesterolemia has been previously reported to negatively impact mortality in the general population.
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The lower lymphocyte count has been shown to lead to worse outcomes in subjects with coronary artery disease. 
Complete blood cell count
Hematocrit ( In a study conducted by Shiyovich et al., it was revealed that the lymphocyte count, the neutrophil-to-lymphocyte ratio, and the eosinophil count were independently associated with long-term mortality following an AMI. 30 Similarly, our results indicated a significantly lower lymphocyte count and a higher neutrophil/lymphocyte count in patients with impaired nutritional status, who also presented a higher rate of in-hospital complications.
The findings of the present study indicated that patients with moderate to severe impairment of the nutritional status, assessed with the CONUT index, are at in- . 23 The present study focused on patients with AMI, and one of the major end-points consisted in the development of acute heart failure secondary to the acute ischemic event, which has been incompletely studied. Our results proved that subjects with malnutrition are more likely to develop acute heart failure and hemodynamic instability compared to patients with normal or mildly decreased CONUT score.
Coronary artery disease severity and prognosis have also been reported by various studies in which the CONUT score was found to be an independent predictor of longterm adverse cardiac events. 24, 31 Furthermore, it appears that the CONUT index can predict short and mid-term all-cause mortality in hypertensive patients, as reported with a nutrition specialist in case of hospitalized patients, in order to provide active management of malnutrition, which may improve outcomes both on short and long term.
Study limitAtionS And future directionS
The main limitation of the study was that it was a singlecenter, observational one, with a relatively low number of 
CONCLuSIONS
This study proved that nutritional deficit is associated with an increased rate of complications during hospital stay in patients with AMI. Patients with a CONUT score higher than 3 points (moderate to severe malnutrition)
presented an increased rate of acute heart failure with hemodynamic instability and requirement of inotropic therapy and required longer observation times in the intensive cardiac care unit, compared to subjects with a CO-NUT score of <3 points (normal to mildly impaired nutritional status). The screening of malnutrition in patients hospitalized for AMI could lead to decreased in-hospital adverse events, shorter admission periods, and consequently lower healthcare costs.
